Source: Covexit.com

video

We are pleased to present a webinar about a crucial topic: the early treatment of those catching COVID-19, especially with the Delta variant.

The Delta, which represents the vast majority of new cases in the US and many other countries, requires indeed a slightly different approach for its early treatment.

Four distinguished medical doctors, not only highly knowledgeable with the treatment of COVID-19, but also with direct experience in treating patients with Delta, participated in the event: Dr Ryan Cole from Idaho, USA, Dr Shankara Chetty from South Africa, Dr Pierre Kory, from NY, USA, and Dr Richard Urso from Texas, USA.

Dr. Ryan Cole is a board-certified dermatopathologist (AP & CP) and the CEO/Medical Director of Cole Diagnostics. He has worked as an independent pathologist since 2004.
Some highlights from his CV:
Ackerman Academy of Dermatopathology (July 2002-June 2003): Dermatopathology Fellowship (Chief Fellow).
Mayo Clinic (July 1997-June 2002): Resident in Anatomic and Clinical Pathology. Chief Fellow, Surgical Pathology Fellowship. Medical College of Virginia (1993-1997): Researched immunology. Served as President of Student Family Practice organization. Coordinated activities and seminars on the practice of family medicine and rural medicine. Earned MD in 1997.






Related:

The Early Treatment of Delta: Part 2 – Dr Shankara Chetty

The Early Treatment of Delta: Part 3 – Dr Pierre Kory

The Early Treatment of Delta: Part 4 – Dr Richard Urso

UK: Dr Tess Lawrie speaks about ivermectin and the authorities

‘It’s crystal clear’: Professor Robert Clancy backs ivermectin as a COVID-19 treatment

USA: Omaha Doctor Sees Tremendous Success with Ivermectin as Early Treatment Against COVID-19

UK-based Meta Analysis Peer Reviewed & Published Suggests Ivermectin A Key Public Health Weapon in the War Against COVID-19

Study: Ivermectin can lead to “large reductions” in Covid-19 deaths

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Stark madness to ban ivermectin

Buried in the note is the real reason for making ivermectin inaccessible – the fear that persons taking it ‘may elect not to be vaccinated as part of the national Covid-19 vaccination program’. This is outrageous. When someone is infected with Covid, it is too late to bother with vaccination. They need early treatment. To deny it to coerce them into accepting a vaccine, one of whose side-effects is death, is immoral.

Read More »

Australia’s TGA Bans GPs from Prescribing Ivermectin

Australia’s medicine and therapeutic regulatory, the Therapeutic Good Administration (TGA) recently took the gloves off with Ivermectin, the economical anti-parasitic drug associated with at least 63 completed clinical trials involving SARS-CoV-2, the virus behind COVID-19. Now TGA formally places a national prohibition on off-label prescribing of ivermectin to all general practitioners. A comparable move as to what TGA did with hydroxychloroquine in 2020. Clearly further evidence of tightening encroachment of the critically important doctor-patient treatment relationship allowing consent to medical treatment using off-label medications. Of course, this isn’t occurring in a vacuum—it’s part of an unfolding, integrated and what have the signs of a coordinated and orchestrated government action to stop any and all treatments other than those the government declares acceptable.

Read More »